Ildong Holdings Co., Ltd. (KRX:000230)
South Korea
· Delayed Price · Currency is KRW 10,080
-10 (-0.10%)
Apr 29, 2026, 3:30 PM KST
Ildong Holdings Revenue
In the year 2025, Ildong Holdings had annual revenue of 590.89B KRW, down -6.90%. Ildong Holdings had revenue of 153.83B in the quarter ending December 31, 2025, a decrease of -4.14%.
Revenue
590.89B
Revenue Growth
-6.90%
P/S Ratio
0.19
Revenue / Employee
8.21B
Employees
72
Market Cap
113.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 590.89B | -43.76B | -6.90% |
| Dec 31, 2024 | 634.65B | -3.79B | -0.59% |
| Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
| Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
| Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CKD Bio | 159.93B |
| HANDOK | 535.14B |
| Kukje Pharma | 175.50B |
| Jeil Pharma Holdings | 657.61B |
| Ilsung Is | 64.29B |
| Kyongbo Pharmaceutical | 264.10B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| Daihan Pharmaceutical | 208.61B |